Belhaven Biopharma Inc. — Form D

Belhaven Biopharma Inc. of Chapel Hill, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-15. The offering totals $32.3M, of which $32.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-10-15
• Form: D
• Accession: 0001231919-25-000318
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $32.3M
• Amount sold: $32.3M
• Investors: 222
• Date of first sale: 2025-08-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-560900

Issuer

• Name: Belhaven Biopharma Inc.
• CIK: 0001873965
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 84406 Winslow, Chapel Hill, NC, 27517
• Phone: 919-656-8658

Officers, directors & promoters (6)

More

• CIK 1873965 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search